Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geert D'Haens

Showing results (101-110 of 269) with videos related to

Pageof 27
Sort By:
Gastroenterology|April 13, 2005
Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trialPaul Rutgeerts, Gert Van Assche, Séverine Vermeire, et al.
Gastroenterology|January 10, 2002
Budesonide in collagenous colitis: a double-blind placebo-controlled trial with histologic follow-upFilip Baert, Alain Schmit, Geert D'Haens, et al.
Alimentary Pharmacology & Therapeutics|November 23, 2019
Prevalence of endoscopic improvement and remission according to patient-reported outcomes in ulcerative colitisParambir S Dulai, Siddharth Singh, Vipul Jairath, et al.
United European Gastroenterology Journal|May 13, 2022
Observational data from the adalimumab post-marketing PYRAMID registry of patients with Crohn's disease who became pregnant: A post hoc analysisAilsa Hart, Geert D'Haens, Mareike Bereswill, et al.
International Journal of Molecular Sciences|September 23, 2022
Peripheral Blood DNA Methylation Profiles Do Not Predict Endoscopic Post-Operative Recurrence in Crohn's Disease PatientsVincent W Joustra, Andrew Y F Li Yim, Jessica R de Bruyn, et al.
Expert Opinion on Drug Safety|July 21, 2022
Safety and tolerability of spesolimab in patients with ulcerative colitisMarc Ferrante, Peter M Irving, Christian P Selinger, et al.
Journal of Crohn'S & Colitis|June 22, 2015
Budesonide MMX for the Induction of Remission of Mild to Moderate Ulcerative Colitis: A Pooled Safety AnalysisGary R Lichtenstein, Simon Travis, Silvio Danese, et al.
The Cochrane Database of Systematic Reviews|August 9, 2016
Endoscopic scoring indices for evaluation of disease activity in Crohn's diseaseReena Khanna, Sigrid A Nelson, Brian G Feagan, et al.
The American Journal of Gastroenterology|December 19, 2019
Mongersen (GED-0301) for Active Crohn's Disease: Results of a Phase 3 StudyBruce E Sands, Brian G Feagan, William J Sandborn, et al.
Inflammatory Bowel Diseases|June 28, 2021
Disease Activity Indices for Pouchitis: A Systematic ReviewRocio Sedano, Tran M Nguyen, Ahmed Almradi, et al.
Pageof 27

Showing results (101-110 of 269) with videos related to

Sort By:
Pageof 27
Gastroenterology|April 13, 2005
Ornidazole for prophylaxis of postoperative Crohn's disease recurrence: a randomized, double-blind, placebo-controlled trialPaul Rutgeerts, Gert Van Assche, Séverine Vermeire, et al.
Gastroenterology|January 10, 2002
Budesonide in collagenous colitis: a double-blind placebo-controlled trial with histologic follow-upFilip Baert, Alain Schmit, Geert D'Haens, et al.
Alimentary Pharmacology & Therapeutics|November 23, 2019
Prevalence of endoscopic improvement and remission according to patient-reported outcomes in ulcerative colitisParambir S Dulai, Siddharth Singh, Vipul Jairath, et al.
United European Gastroenterology Journal|May 13, 2022
Observational data from the adalimumab post-marketing PYRAMID registry of patients with Crohn's disease who became pregnant: A post hoc analysisAilsa Hart, Geert D'Haens, Mareike Bereswill, et al.
International Journal of Molecular Sciences|September 23, 2022
Peripheral Blood DNA Methylation Profiles Do Not Predict Endoscopic Post-Operative Recurrence in Crohn's Disease PatientsVincent W Joustra, Andrew Y F Li Yim, Jessica R de Bruyn, et al.
Expert Opinion on Drug Safety|July 21, 2022
Safety and tolerability of spesolimab in patients with ulcerative colitisMarc Ferrante, Peter M Irving, Christian P Selinger, et al.
Journal of Crohn'S & Colitis|June 22, 2015
Budesonide MMX for the Induction of Remission of Mild to Moderate Ulcerative Colitis: A Pooled Safety AnalysisGary R Lichtenstein, Simon Travis, Silvio Danese, et al.
The Cochrane Database of Systematic Reviews|August 9, 2016
Endoscopic scoring indices for evaluation of disease activity in Crohn's diseaseReena Khanna, Sigrid A Nelson, Brian G Feagan, et al.
The American Journal of Gastroenterology|December 19, 2019
Mongersen (GED-0301) for Active Crohn's Disease: Results of a Phase 3 StudyBruce E Sands, Brian G Feagan, William J Sandborn, et al.
Inflammatory Bowel Diseases|June 28, 2021
Disease Activity Indices for Pouchitis: A Systematic ReviewRocio Sedano, Tran M Nguyen, Ahmed Almradi, et al.
Pageof 27